{"entity":{"type":"insider","cik":"0001810387","url":"/insider/0001810387","json_url":"/insider/0001810387.json","name":"Biogen MA Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2021-11-30","last":"2023-09-28","span_basis":"filed_date"},"name_variants":[{"name":"Biogen MA Inc.","source":"filing","n_filings":8,"first_seen":"2021-11-30","last_seen":"2023-09-28"}],"transactions":[{"id":7962199,"accession":"0000899243-23-019611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-019611","line_url":"/filing/0000899243-23-019611#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"BIOGEN INC.; Biogen MA Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000000.0,"shares_display":"6,000,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":17652466.0,"shares_owned_after_display":"17,652,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-28","scope":"insider"},{"id":6714578,"accession":"0000899243-22-030136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030136","line_url":"/filing/0000899243-22-030136#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"BIOGEN INC.; Biogen MA Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.2652,"price_display":"5.27","price_state":"stated","total_value":526520.0,"total_display":"526,520.00","shares_owned_after":23652466.0,"shares_owned_after_display":"23,652,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-30","filed_date":"2022-08-31","scope":"insider"},{"id":6714571,"accession":"0000899243-22-030136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-030136","line_url":"/filing/0000899243-22-030136#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"BIOGEN INC.; Biogen MA Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":5.3268,"price_display":"5.33","price_state":"stated","total_value":2130720.0,"total_display":"2,130,720.00","shares_owned_after":23752466.0,"shares_owned_after_display":"23,752,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-08-31","scope":"insider"},{"id":4449754,"accession":"0000875045-21-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875045-21-000061","line_url":"/filing/0000875045-21-000061#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2764.0,"shares_display":"2,764","price_per_share":8.5101,"price_display":"8.51","price_state":"stated","total_value":23521.9164,"total_display":"23,521.92","shares_owned_after":24152466.0,"shares_owned_after_display":"24,152,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-30","scope":"insider"},{"id":4651966,"accession":"0000875045-21-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875045-21-000060","line_url":"/filing/0000875045-21-000060#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":8.56,"price_display":"8.56","price_state":"stated","total_value":5136.0,"total_display":"5,136.00","shares_owned_after":24155230.0,"shares_owned_after_display":"24,155,230","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-28","scope":"insider"},{"id":4651948,"accession":"0000875045-21-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875045-21-000060","line_url":"/filing/0000875045-21-000060#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81187.0,"shares_display":"81,187","price_per_share":8.5547,"price_display":"8.55","price_state":"stated","total_value":694530.4289,"total_display":"694,530.43","shares_owned_after":24155830.0,"shares_owned_after_display":"24,155,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-28","scope":"insider"},{"id":4602807,"accession":"0000875045-21-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875045-21-000059","line_url":"/filing/0000875045-21-000059#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"BIOGEN INC.; Biogen MA Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23660.0,"shares_display":"23,660","price_per_share":8.5605,"price_display":"8.56","price_state":"stated","total_value":202541.43,"total_display":"202,541.43","shares_owned_after":24237017.0,"shares_owned_after_display":"24,237,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-10","scope":"insider"},{"id":4918208,"accession":"0000875045-21-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875045-21-000058","line_url":"/filing/0000875045-21-000058#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75814.0,"shares_display":"75,814","price_per_share":8.6373,"price_display":"8.64","price_state":"stated","total_value":654828.2622,"total_display":"654,828.26","shares_owned_after":24260677.0,"shares_owned_after_display":"24,260,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-09","scope":"insider"},{"id":4918205,"accession":"0000875045-21-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875045-21-000058","line_url":"/filing/0000875045-21-000058#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52178.0,"shares_display":"52,178","price_per_share":8.5177,"price_display":"8.52","price_state":"stated","total_value":444436.5506,"total_display":"444,436.55","shares_owned_after":24336491.0,"shares_owned_after_display":"24,336,491","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-09","scope":"insider"},{"id":4203208,"accession":"0000875045-21-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875045-21-000057","line_url":"/filing/0000875045-21-000057#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1874.0,"shares_display":"1,874","price_per_share":8.5074,"price_display":"8.51","price_state":"stated","total_value":15942.8676,"total_display":"15,942.87","shares_owned_after":24388669.0,"shares_owned_after_display":"24,388,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-03","scope":"insider"},{"id":4203204,"accession":"0000875045-21-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875045-21-000057","line_url":"/filing/0000875045-21-000057#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":730.0,"shares_display":"730","price_per_share":8.5249,"price_display":"8.52","price_state":"stated","total_value":6223.177,"total_display":"6,223.18","shares_owned_after":24390543.0,"shares_owned_after_display":"24,390,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider"},{"id":4403274,"accession":"0000875045-21-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875045-21-000055","line_url":"/filing/0000875045-21-000055#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":null,"owner_name":"Biogen MA Inc.; BIOGEN INC.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28884.0,"shares_display":"28,884","price_per_share":8.6011,"price_display":"8.60","price_state":"stated","total_value":248434.1724,"total_display":"248,434.17","shares_owned_after":24391273.0,"shares_owned_after_display":"24,391,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001001233","name":"SANGAMO THERAPEUTICS, INC","url":"/issuer/0001001233","role":"Ten percent owner","n_filings":8,"first_seen":"2021-11-30","last_seen":"2023-09-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001810387","retrieved_at":"2026-08-21T02:01:35+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}